A historical look at how prescribing practices and society recommendations have evolved over time including the latest updates at the cutting edge of menopausal management with hormone therapy.
Key Takeaways:
- Describe the current FDA-approved indications for hormone therapy
- Summarize the main points about what we know and what needs more study from the most recent, 2022 Menopause Society Hormone Therapy Position Statement
- Gain a general understanding of the data surrounding hormone therapy in breast cancer survivors and the general approach to assessing risks and benefits in this population.
| Attachment | Size |
|---|---|
 PDF - Hormone Therapy.pdf | 975.5 KB |
9:00am Central
(7:00am Pacific / 10:00am Eastern)
On Oct 26th, 2025
This page will refresh at the start of the session.
You can also
refresh the page manually.
In the meantime, join the conversation.
Carla DiGirolamo, MD
Dr. Carla DiGirolamo is a double Board-Certified Obstetrician/Gynecologist, Reproductive
Endocrinologist, and Menopause Society Certified Practitioner with over 20 years of experience as a Women’s Health and Reproductive Specialist. She was named among Boston Magazine’s Top Doctors in the Boston area from 2019-2025. She has also been in the fitness industry for decades as a recreational athlete and fitness professional, as a CrossFit Level 1 Trainer and Certified Nutrition Coach.
